|
1) Stan RV, Ghitescu L, Jacobson BS, et al. Isolation, cloning, and localization of rat PV-1, a novel endothelial caveolar protein. J Cell Biol. 1999; 145: 1189-98
|
|
|
|
2) Stan RV. Multiple PV1 dimers reside in the same stomatal or fenestral diaphragm. Am J Physiol Heart Circ Physiol. 2004; 286: 1347-53
|
|
|
|
|
|
3) Stan RV. Endothelial stomatal and fenestral diaphragms in normal vessels and angiogenesis. J Cell Mol Med. 2007; 11: 621-43
|
|
|
|
|
|
4) Stan RV. Structure of caveolae. Biochimica et Biophysica Acta. 2005; 1746: 334-48
|
|
|
|
|
|
5) Stan RV, Kubitza M, Palade GE. PV-1 is a component of the fenestral and stomatal diaphragms in fenestrated endothelia. Proc Natl Acad Sci U S A. 1999; 96: 13203-7
|
|
|
|
|
|
6) Niemela H, Elima K, Henttinen T, et al. Molecular identification of PAL-E, a widely used endothelical-cell marker. Blood. 2005; 106: 3405-9
|
|
|
|
|
|
7) Yamamoto I, Horita S, Takahashi T, et al. Glomerular expression of plasmalemmal vesicle-associated protein-1 in patients with transplant glomerulopathy. Am J Transplant. 2007; 7: 1954-60
|
|
|
|
|
|
8) Yamamoto I, Horita S, Takahashi T, et al. Caveolin-1 expression is a distinct feature of chronic rejection-induced transplant capillaropathy. Am J Transplant. 2008; 8: 2627-35
|
|
|
|
|
|
9) Pannabecker TL, Dantzler WH. Three-dimensional architecture of inner medullary vasa recta. Am J Physiol Renal Physiol. 2006; 290: F1355- 66
|
|
|
|
|
|
10) Sarawar SR, Schlingemann RO, Kelsey A, et al. A monoclonal antibody stains blastemal but not tubular components of Wilms' tumour. J Pathol. 1988; 156: 319-24
|
|
|
|
|
|
11) Ichimura K, Stan RV, Kurihara H, et al. Glomerular endothelial cells form diaphragms during development and pathologic conditions. J Am Soc Nephrol. 2008; 19: 1463-71
|
|
|
|
|
|
12) Eremina V, Jefferson JA, Kowalewska J, et al. VEGF inhibition and renal thrombotic microangiopathy. N Engl J Med. 2008: 358: 1129-36
|
|
|
|
|
|
13) Maynard SE, Min JY, Merchan J, et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest. 2003: 111: 649-58
|
|
|
|
|
|
14) Sugimoto H, Hamano Y, Charytan D, et al. Neutralization of circulating vascular endothelial growth factor (VEGF) by anti-VEGF antibodies and soluble VEGF receptor 1 (sFlt-1) induces proteinuria. J Biol Chem. 2003: 278: 12605-8
|
|
|
|
|
|
15) Quaggin SE, Kreidberg JA. Development of the renal glomerulus: good neighbors and good fences. Development. 2008; 135: 609-20
|
|
|
|
|
|
16) Robert B, Zhao X, Abrahamson DR. Coexpression of neuropilin-1, Flk1, and VEGF(164) in developing and mature mouse kidney glomeruli. Am J Physiol Renal Physiol. 2000; 279: F275-82
|
|
|
|
|
|
17) Strickland LA, Jubb AM, Hongo JA, et al. Plasmalemmal vesicle-associated protein (PLVAP) is expressed by tumour endothelium and is upregulated by vascular endothelial growth factor-A (VEGF). J Pathol. 2005; 206: 466-75
|
|
|
|
|
|
18) Carson-Walter EB, Hampton J, Shue E, et al. Plasmalemmal vesicle associated protein-1 is a novel marker implicated in brain tumor angiogenesis. Clin Cancer Res. 2005: 11: 7643-50
|
|
|
|
|
|
19) Satchell SC, Braet F. Glomerular endothelial cell fenestrations: an integral component of the glomerular filtration barrier. Am J Physiol Renal Physiol. 2009; 296: F947-56
|
|
|
|
|
|
20) Hnasko R, Frank PG, Ben-Jonathan N, et al. PV-1 is negatively regulated by VEGF in the lung of caveolin-1, but not caveolin-2, null mice. Cell Cycle. 2006; 5: 2012-20
|
|
|
|
|
|
21) Solez K, Colvin RB, Racusen, LC, et al. Banff'05 Meeting Report: differential diagnosis of chronic allograft injury and elimination of chronic allograft nephropathy (‘CAN'). Am J Transplant. 2007; 7: 518-26
|
|
|
|
|
|
22) Johannes Keuschnigg J, Henttinen T, Auvinen K, et al. The prototype endothelial marker PAL-E is a leukocyte trafficking molecule. Blood. 2009; 114: 478-84
|
|
|
|
|
|
23) Takemoto SK, Zeevi A, Feng S, et al. National conference to assess antibody-mediated rejection in solid organ transplantation. Am J Transplant. 2004; 4: 1033-41
|
|
|
|
|
|
24) Palade GE. Fine structure of blood capillaries. J Appl Phys. 1953; 24: 1424
|
|
|
|
|
|
25) Frank PG, Woodman SE, Park DS, et al. Caveolin, caveolae, and endothelial cell function. Arterioscler Thromb Vasc Biol. 2003; 23: 1161-8
|
|
|
|
|
|
26) Razani B, Woodman SE, Lisanti MP. Caveolae: From cell biology to animal physiology. Pharmacol Rev. 2002; 54: 431-67
|
|
|
|
|
|
27) Rothberg KG, Heuser JE, Donzell WC, et al. Caveolin, a protein component of caveolae membrane coats. Cell. 1992; 68: 673-82
|
|
|
|
|
|
28) Garcia E, Li M. Caveolin-1 immunohistochemical analysis in differentiating chromophobe renal cell carcinoma from renal oncocytoma. Am J Clin Pathology. 2006; 125: 392-8
|
|
|
|
|
|
29) Ostalska-Nowicka D, Nowicki M, Zachwieja J, et al. The significance of caveolin-1 expression in parietal epithelial cells of Bowman's capsule. Histopathology. 2007; 51: 611-21
|
|
|
|
|
|
30) Sörensson J, Fierlbeck W, Heider T, et al. Glomerular endothelial fenestrae in vivo are not formed from caveolae. J Am Soc Nephrol. 2002; 13: 2639-47
|
|
|
|
|
|
31) Bauer PM, Yu J, Chen Y, et al. Endothelial-specific expression of caveolin-1 impairs microvascular permeability and angiogenesis. Proc Natl Acad Sci U S A. 2005; 102: 204-9
|
|
|
|
|
|
32) Lin MI, Yu J, Murata T, et al. Caveolin-1-deficient mice have increased tumor microvascular permeability, angiogenesis, and growth. Cancer Res. 2007; 67: 2849-56
|
|
|
|
|
|
33) Torres VA, Tapia JC, Rodríguez DA, et al. Caveolin-1 controls cell proliferation and cell death by suppressing expression of the inhibitor of apoptosis protein surviving. J Cell Sci. 2006; 119: 1812-3
|
|
|
|
|
|
34) Fang K, Fu W, Beardsley AR, et al. Overexpression of caveolin-1 inhibits endothelial cell proliferation by arresting the cell cycle. at G0/G1 phase. Cell Cycle. 2007; 6: 199-204
|
|
|
|
|
|
35) Frank PG, Woodman SE, Park DS, et al. Caveolin, caveolae, and endothelial cell function. Arterioscler Thromb Vasc Biol. 2003; 23: 1161-8
|
|
|
|
|
|
36) Gálvez BG, Matías-Román S, Yáñez-Mó M, et al. Caveolae are a novel pathway for membrane-type 1 matrix metalloproteinase traffic in human endothelial cells. MBC. 2004; 15: 678-87
|
|
|
|
|